Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 42INDUSTRY 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 9Lymphoid 9Myeloid 4Other neoplasm 2Sarcoma 1Plasma cell 1Genitourinary 1Classical hematology 1Breast 1

Conditions

Lymphoma, Follicular 1Anemia, Aplastic 1

Interventions

Radiotherapy 5Methotrexate 4Cytarabine 4Cyclophosphamide 4Epoetin Alfa 3Daunorubicin 3Cyclosporine 3Thioguanine 2Peripheral Blood Stem Cell Transplantation 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Dexamethasone 2Cisplatin 2Busulfan 2Asparaginase 2zosuquidar trihydrochloride 1thymoglobulin 1sargramostim 1merphos 1hydrocortisone hemisuccinate 1fludarabine 1Whole-Body Irradiation 1Vincristine 1Thrombopoietin 1Stem Cell Transplantation 1Prednisone 1Photopheresis 1Pentostatin 1Mycophenolic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × fludarabine × Classical hematology × Clear all
NCT00737685 2012-03-26

Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)

The Korean Society of Pediatric Hematology Oncology

Phase 2 Unknown
30 enrolled
Classical hematologyLymphoid

Anemia, Aplastic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡